Evidence map›Paper›PMID 33965428›Full record

ArticleThe Journal of infection2021

Effectiveness of BNT162b2 vaccine against the B.1.1.7 variant of SARS-CoV-2 among healthcare workers in Brescia, Italy.

E Sansone, M Tiraboschi, E Sala, E Albini, M Lombardo, F Castelli, G De Palma

Open access · bronzeAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

E SansoneUnit of Occupational Health and Industrial Hygiene, DSMC, University of Brescia, Brescia, Italy.
M TiraboschiUnit of Occupational Health and Industrial Hygiene, DSMC, University of Brescia, Brescia, Italy.
E SalaUnit of Occupational Health, Hygiene, Toxicology and Prevention, ASST Spedali Civili, 25123, Brescia, Italy.
E AlbiniUnit of Occupational Health, Hygiene, Toxicology and Prevention, ASST Spedali Civili, 25123, Brescia, Italy.
M LombardoChief Executive Office, ASST Spedali Civili di Brescia, Brescia, Italy.
F CastelliUniversity Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili, 25123 Brescia, Italy.
G De PalmaUnit of Occupational Health and Industrial Hygiene, DSMC, University of Brescia, Brescia, Italy; Unit of Occupational Health, Hygiene, Toxicology and Prevention, ASST Spedali Civili, 25123, Brescia, Italy. Electronic address: giuseppe.depalma@unibs.it.
University of Brescia · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19VaccinesBNT162 VaccineCOVID-19 VaccinesHealth PersonnelHumansItalySARS-CoV-2BNT162 VaccineCOVID-19 VaccinesVaccines

Identifiers

PMID33965428
PMCPMC8102078
OpenAlexW3163939566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.